BioCentury
ARTICLE | Company News

Curalogic inflammation, autoimmune news

December 22, 2008 8:00 AM UTC

Curalogic will liquidate based on the board's recommendation. The company estimates shareholders could receive DKK273-281 million ($49.3-$50.7 million). In January, the company discontinued developmen...